Quinapril Hydrochloride/hydrochlorothiazide recalls
Quinapril Hydrochloride/hydrochlorothiazide products have been recalled 1 time, most recently on 2 Nov 2022. The recalling company is usually Aurobindo Pharma USA. The most common reason is nitrosamine impurity.
Total recalls1since 2022
Last 12 months0reported
Class I00% of total
Ongoing0latest 2 Nov 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why quinapril hydrochloride/hydrochlorothiazide is recalled
Companies
Product types
By year
All quinapril hydrochloride/hydrochlorothiazide recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Quinapril and Hydrochlorothiazide Tablets, USP 20mg/12.5mg recalledQuinapril Hydrochloride/hydrochlorothiazide | Aurobindo Pharma USA | Nitrosamine Impurity | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.